Pathological tissue detection and treatment employing targeted benzoindole optical agents
US7128896B2 · kind B2 · utility
20Cited by
12References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 17, 2004 |
| Grant date | Oct 31, 2006 |
| Priority date | — |
| Expiry date | Jan 18, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC09B47/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel tumor specific phototherapeutic and photodiagnostic agents are disclosed. The compounds consist of a carbocyanine dye for visualization, photosensitizer for photodynamic treatment, and tumor receptor-avid peptide for site-specific delivery of the probe and phototoxic agent to diseased tissues. A combination of these elements takes full advantage of the unique and efficient properties of each component for an effective patient care management.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.